HomeTagsVamorolone

Vamorolone

Santhera Enters into Agreement with Ikris Pharma Network for the Distribution of AGAMREE (Vamorolone) in India

Agamree to be sold in United Arab Emirates, Saudi Arabia, Kuwait, Oman and Bahrain starting in 2026

Santhera Secures Agreement with GEN for the Distribution of AGAMREE (Vamorolone) in Turkiye

Agamree (vamorolone) will be Covered in Slovenia by the Slovenian Health Insurance Fund

New Drug Submission for AGAMREE (vamorolone) Accepted for Priority Review by Health Canada for the Treatment of Duchenne Muscular Dystrophy

Miraculous Steroid Vamorolone (Agamree) Could Offer Safer Treatment for DMD

Santhera Announces Agreement with German GKV-SV on Reimbursement Amount for AGAMREE® (vamorolone) for the Treatment of Duchenne Muscular Dystrophy in Germany

Approved Therapies

NICE Final Guidance for AGAMREE (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy Is Positive for Santhera

Approved Therapies

Vamorolone (Agamree) Approved in Scotland

123 Page 2 of 3

Popular

Frequently Asked Questions About Elevidys Used for DMD

Can Ekinci - August 21, 2026

Must Read

Do Social Media Hashtag Campaigns Really Help DMD Associations Improve Access to Approved Treatments for DMD Families?

IPS HEART Aims to Restore Full-Length Dystrophin with Two Regenerative Cell Therapies for Duchenne Muscular Dystrophy

20 Important Things You Need to Know About DMD Genetic Testing

About us

Together, we will keep fighting for better treatments and access for everyone with Duchenne.

Powered by Hostinger

Latest Articles

What Is Duchenne Muscular Dystrophy (DMD)?: 108 FAQs

DMD October 20, 2026 1

Duchenne muscular dystrophy (DMD), commonly known as Duchenne, is...

Entrada Therapeutics ENTR-601-45: Early Exon 45 Skipping Study Shows Increased Dystrophin Production

Press Releases October 14, 2026 0

Entrada Therapeutics has announced positive initial results from its...

Entrada Therapeutics Advances ENTR-601-44 to 18 mg/kg in Its Duchenne Exon 44 Skipping Study

Press Releases October 14, 2026 0

Entrada Therapeutics has received clearance to test the highest...

Most Popular

Frequently Asked Questions About Elevidys Used for DMD

Approved Therapies August 21, 2026 0

Duchenne muscular dystrophy (DMD) is a genetic condition that...

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Editorials April 10, 2026 0

The landscape of potential new gene therapies for Duchenne...

The Brutal Truth: Why Duchenne Muscular Dystrophy Treatment Costs Are Out of Control

Editorials April 6, 2026 0

The duchenne muscular dystrophy treatment cost has become one...

© 2024 - 2026 DMD Warrior. All rights reserved.